Emily L. G. Heaphy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Emily L. G. Heaphy has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Lama Hefni
Medicine Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
2 shared publicationsAbdullah Alraddadi
Medicine Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
1 shared publication- Abdulrahman M. Habib
Pediatrics ,King Faisal Specialist Hospital and Research Centre ,Jeddah,Saudi Arabia, Saudi Arabia
1 shared publication Abeer N Alshukairi
Medicine Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
1 shared publicationAhmad M. Alshahrani
King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
1 shared publication- Amjad Ahmed Aljagthmi
Research center, King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by MDPI AG in Preprints.org
Glycemic Control and Social Challenges Among Saudi Children with Type 1 Diabetes Mellitus: The Impact of Virtual Clinics
Background: A type 1 diabetes mellitus (T1DM) diagnosis is burdensome for pediatric patients and for healthcare systems globally. Glycemic control is pivotal in managing T1DM while the psychosocial aspects of the disease can be overlooked. Telemedicine provides a potential solution to enhance diabetes care and to reduce barriers faced by patients, particularly in remote areas. We aimed to explore the impact of monthly virtual clinics on glycemic control in pediatric patients and to assess psychosocial aspects of the disease by measuring parents’ satisfaction with these clinics. Methods: This single-center cohort study enrolled pediatric patients aged 14 years or younger with T1DM at the King Faisal Specialist Hospital and Research Center – Jeddah Branch. Data collection occurred over a six-month period with patients participating in monthly virtual consultations in addition to their regular in-person clinic visits. Parental satisfaction and compe-tence in diabetes management were assessed using a survey developed for study use. Clinical and demographic variables were compared before and after the intervention. Results: The study in-cluded 25 participants, with a median age of 11.0 years and 56.0% were male. Following the in-tervention, there was a significant improvement in HbA1c levels (pre-intervention: 9.3 ± 1.7, post-intervention: 8.8 ± 1.6, p-value = 0.0054) and a reduction in the number of hypoglycemia ep-isodes per week. Parental satisfaction and competence in managing T1DM remained consistent throughout the study. Conclusions: This study suggests that implementing monthly virtual clin-ics can positively impact glycemic control and reduce hypoglycemia episodes in pediatric T1DM patients in Saudi Arabia. Future research should explore the long-term benefits and scalability of telemedicine in managing chronic pediatric conditions and its acceptance by parents of Saudi children with T1DM.
- 29 September 2026
- Published by MDPI AG in Preprints.org
Open AccessGlycemic Control and Social Challenges Among Saudi Children with Type 1 Diabetes Mellitus: The Impact of Virtual Clinics
Background: A type 1 diabetes mellitus (T1DM) diagnosis is burdensome for pediatric patients and for healthcare systems globally. Glycemic control is pivotal in managing T1DM while the psychosocial aspects of the disease can be overlooked. Telemedicine provides a potential solution to enhance diabetes care and to reduce barriers faced by patients, particularly in remote areas. We aimed to explore the impact of monthly virtual clinics on glycemic control in pediatric patients and to assess psychosocial aspects of the disease by measuring parents’ satisfaction with these clinics. Methods: This single-center cohort study enrolled pediatric patients aged 14 years or younger with T1DM at the King Faisal Specialist Hospital and Research Center – Jeddah Branch. Data collection occurred over a six-month period with patients participating in monthly virtual consultations in addition to their regular in-person clinic visits. Parental satisfaction and compe-tence in diabetes management were assessed using a survey developed for study use. Clinical and demographic variables were compared before and after the intervention. Results: The study in-cluded 25 participants, with a median age of 11.0 years and 56.0% were male. Following the in-tervention, there was a significant improvement in HbA1c levels (pre-intervention: 9.3 ± 1.7, post-intervention: 8.8 ± 1.6, p-value = 0.0054) and a reduction in the number of hypoglycemia ep-isodes per week. Parental satisfaction and competence in managing T1DM remained consistent throughout the study. Conclusions: This study suggests that implementing monthly virtual clin-ics can positively impact glycemic control and reduce hypoglycemia episodes in pediatric T1DM patients in Saudi Arabia. Future research should explore the long-term benefits and scalability of telemedicine in managing chronic pediatric conditions and its acceptance by parents of Saudi children with T1DM.
- Open Access
- 19 August 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1619611
Epidemiology and outcomes of Carbapenem-resistant Enterobacterales infection in high-risk patients in Saudi Arabia
Introduction: Solid organ transplant (SOT) recipients, bone marrow transplant (BMT) recipients, and patients with hematological malignancies experience increased morbidity due to infections caused by multidrug-resistant, Carbapenem-resistant Enterobacterales (CRE). The current study aimed to further describe the epidemiology and outcomes associated with CRE infection in high-risk SOT and BMT recipients and in patients with hematological malignancies in Saudi Arabia.Methods: Patients aged 16 years and older admitted to a participating hospital between October 2018 and August 2024 who received an SOT or a BMT or were diagnosed with a hematological malignancy and had a confirmed CRE infection were included in this retrospective cohort study. A total of 155 eligible patients were included in the study population. The primary outcome of interest was all-cause mortality within 90 days of the date of the first CRE culture.Results: Among the 155 patients, 118 (76.1%) had received a solid organ transplant, while 37 (23.9%) had either a bone marrow transplant or a hematological malignancy. The BMT recipients and patients with hematological malignancies were 2.84 times more likely to die within 90 days of their first positive culture [adjusted odds ratio (AOR) = 2.84, 95% confidence interval (CI) = 1.01–8.01, p = 0.049]. Compared to the patients with CRE infections carrying the blaNDM gene, after controlling for other predictors, patients with infections harboring the blaOXA-48 gene were 3.97 times more likely to die within 90 days of the first culture (AOR = 3.97, 95%CI = 1.04–15.15, p = 0.044).Conclusion: The BMT recipients and patients with CRE infections harboring the blaOXA-48 gene were at greater risk for 90-day all-cause mortality in Saudi Arabia, confirming previous findings of high mortality rates associated with CRE infections in immunocompromised populations.
- 19 August 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1619611
Open AccessEpidemiology and outcomes of Carbapenem-resistant Enterobacterales infection in high-risk patients in Saudi Arabia
Introduction: Solid organ transplant (SOT) recipients, bone marrow transplant (BMT) recipients, and patients with hematological malignancies experience increased morbidity due to infections caused by multidrug-resistant, Carbapenem-resistant Enterobacterales (CRE). The current study aimed to further describe the epidemiology and outcomes associated with CRE infection in high-risk SOT and BMT recipients and in patients with hematological malignancies in Saudi Arabia.Methods: Patients aged 16 years and older admitted to a participating hospital between October 2018 and August 2024 who received an SOT or a BMT or were diagnosed with a hematological malignancy and had a confirmed CRE infection were included in this retrospective cohort study. A total of 155 eligible patients were included in the study population. The primary outcome of interest was all-cause mortality within 90 days of the date of the first CRE culture.Results: Among the 155 patients, 118 (76.1%) had received a solid organ transplant, while 37 (23.9%) had either a bone marrow transplant or a hematological malignancy. The BMT recipients and patients with hematological malignancies were 2.84 times more likely to die within 90 days of their first positive culture [adjusted odds ratio (AOR) = 2.84, 95% confidence interval (CI) = 1.01–8.01, p = 0.049]. Compared to the patients with CRE infections carrying the blaNDM gene, after controlling for other predictors, patients with infections harboring the blaOXA-48 gene were 3.97 times more likely to die within 90 days of the first culture (AOR = 3.97, 95%CI = 1.04–15.15, p = 0.044).Conclusion: The BMT recipients and patients with CRE infections harboring the blaOXA-48 gene were at greater risk for 90-day all-cause mortality in Saudi Arabia, confirming previous findings of high mortality rates associated with CRE infections in immunocompromised populations.
- Open Access
- 1 October 2024
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 17, 4655-4664
Association Between Carbapenem-Resistant Enterobacterales (CRE) Colonization Status at Time of Hospital Admission and the Subsequent Development of CRE Infection and Mortality in High-Risk Patients
Purpose: The study aimed to determine the impact of Carbapenem-resistant Enterobacterales (CRE) colonization status on development of CRE infection and 30-day mortality outcomes in high-risk patients. Patients and Methods: This retrospective cohort study was conducted at King Faisal Specialist Hospital and Research Center in Jeddah, Saudi Arabia from October 2022 to July 2023. It included all patients aged 14 years and older admitted to the intensive care unit (ICU), the renal transplant unit and the oncology units who were screened for CRE colonization upon hospital admission. Results: Overall, 246 patients comprised the study population and 37 patients (56.8% ICU, 13.5% renal transplant unit, and 29.7% oncology units) had a positive CRE screening test. The majority of the isolates (59.5%) were OXA-48. Almost one-third (32.1%) of the patients had diabetes mellitus and 55.3% had any underlying immunosuppression. Eight (3.3%) patients had a confirmed CRE infection and 35 (14.2%) patients died within 30 days of screening. A positive CRE screening test significantly increased the likelihood of 30-day mortality for this high-risk patient population (adjusted odds ratio [AOR] = 3.06, 95% CI = 1.10– 8.51, p = 0.03). Conclusion: A substantial percentage of the high-risk patients had a positive CRE screening test at the time of hospital admission and CRE-colonization status predicted 30-day mortality. Further studies are needed to determine the best practices for CRE screening as a strategy to prevent infection and mortality.
- 1 October 2024
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 17, 4655-4664
Open AccessAssociation Between Carbapenem-Resistant Enterobacterales (CRE) Colonization Status at Time of Hospital Admission and the Subsequent Development of CRE Infection and Mortality in High-Risk Patients
Purpose: The study aimed to determine the impact of Carbapenem-resistant Enterobacterales (CRE) colonization status on development of CRE infection and 30-day mortality outcomes in high-risk patients. Patients and Methods: This retrospective cohort study was conducted at King Faisal Specialist Hospital and Research Center in Jeddah, Saudi Arabia from October 2022 to July 2023. It included all patients aged 14 years and older admitted to the intensive care unit (ICU), the renal transplant unit and the oncology units who were screened for CRE colonization upon hospital admission. Results: Overall, 246 patients comprised the study population and 37 patients (56.8% ICU, 13.5% renal transplant unit, and 29.7% oncology units) had a positive CRE screening test. The majority of the isolates (59.5%) were OXA-48. Almost one-third (32.1%) of the patients had diabetes mellitus and 55.3% had any underlying immunosuppression. Eight (3.3%) patients had a confirmed CRE infection and 35 (14.2%) patients died within 30 days of screening. A positive CRE screening test significantly increased the likelihood of 30-day mortality for this high-risk patient population (adjusted odds ratio [AOR] = 3.06, 95% CI = 1.10– 8.51, p = 0.03). Conclusion: A substantial percentage of the high-risk patients had a positive CRE screening test at the time of hospital admission and CRE-colonization status predicted 30-day mortality. Further studies are needed to determine the best practices for CRE screening as a strategy to prevent infection and mortality.
- Open Access
- 31 January 2024
- Published by MDPI AG in Non-Coding RNA
- Vol. 10 (1) , 10
Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
Non-coding RNAs (ncRNAs) are RNA molecules that do not code for protein but play key roles in regulating cellular processes. NcRNAs globally affect gene expression in diverse physiological and pathological contexts. Functionally important ncRNAs act in chromatin modifications, in mRNA stabilization and translation, and in regulation of various signaling pathways. Non-alcoholic fatty liver disease (NAFLD) is a set of conditions caused by the accumulation of triacylglycerol in the liver. Studies of ncRNA in NAFLD are limited but have demonstrated that ncRNAs play a critical role in the pathogenesis of NAFLD. In this review, we summarize NAFLD’s pathogenesis and clinical features, discuss current treatment options, and review the involvement of ncRNAs as regulatory molecules in NAFLD and its progression to non-alcoholic steatohepatitis (NASH). In addition, we highlight signaling pathways dysregulated in NAFLD and review their crosstalk with ncRNAs. Having a thorough understanding of the disease process’s molecular mechanisms will facilitate development of highly effective diagnostic and therapeutic treatments. Such insights can also inform preventive strategies to minimize the disease’s future development.
- 31 January 2024
- Published by MDPI AG in Non-Coding RNA
- Vol. 10 (1) , 10
Open AccessInvestigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
Non-coding RNAs (ncRNAs) are RNA molecules that do not code for protein but play key roles in regulating cellular processes. NcRNAs globally affect gene expression in diverse physiological and pathological contexts. Functionally important ncRNAs act in chromatin modifications, in mRNA stabilization and translation, and in regulation of various signaling pathways. Non-alcoholic fatty liver disease (NAFLD) is a set of conditions caused by the accumulation of triacylglycerol in the liver. Studies of ncRNA in NAFLD are limited but have demonstrated that ncRNAs play a critical role in the pathogenesis of NAFLD. In this review, we summarize NAFLD’s pathogenesis and clinical features, discuss current treatment options, and review the involvement of ncRNAs as regulatory molecules in NAFLD and its progression to non-alcoholic steatohepatitis (NASH). In addition, we highlight signaling pathways dysregulated in NAFLD and review their crosstalk with ncRNAs. Having a thorough understanding of the disease process’s molecular mechanisms will facilitate development of highly effective diagnostic and therapeutic treatments. Such insights can also inform preventive strategies to minimize the disease’s future development.